In a report released today, Kenneth Talanian from Evercore ISI maintained a Buy rating on Imperva (NASDAQ: IMPV), with a price target of $56. The company’s shares opened today at $45.70.
Talanian wrote:
“We believe this reflects an important shift in focus to billings which (as we have previously stated; see our note here) is a better measure of growth, particularly for a company seeing a greater shift to subscription sales. As with the prior table (see here) this appears to be fairly balanced in its payout structure. We envision it is far easier to outperform operating expenses by up to 9 percentage points than it is to outperform billings by up to 18 percentage points. As a result, we believe this structure suggests that the company will target profitable growth with a slight bias towards profitability which we view as prudent.”
According to TipRanks.com, Talanian is a 4-star analyst with an average return of 14.9% and a 64.4% success rate. Talanian covers the Technology sector, focusing on stocks such as Proofpoint Inc, Symantec Corp, and Check Point.
Imperva has an analyst consensus of Moderate Buy, with a price target consensus of $57.33.
See today’s analyst top recommended stocks >>
The company has a one-year high of $57.65 and a one-year low of $37.17. Currently, Imperva has an average volume of 315.6K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Imperva, Inc. engages in development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications. Its products include web application security, beach prevention, SharePoint, file, cloud, and data security, platform and industry solutions.
